Rowley AH, Shulman STKawasaki disease. In: Kliegman RM, Jenson HB, Behrman RE , et al, eds. Nelson Textbook of Pediatrics. 18th ed. Philadelphia, PA: W B Saunders; 2007:1036-1042.
2.
Yasukawa K., Terai M., Shulman ST, et al. Systemic production of vascular endothelial growth factor and fms-like tyrosine kinase-1 receptor in acute Kawasaki disease. Circulation. 2002;105:766-769.
3.
Amano S., Hazama F., Hamashima Y.Pathology of Kawasaki disease. I. Pathology and morphogenesis of the vascular change. Jpn Circ J.1979;43:633-634.
4.
Sittiwangkul R., Pongprot Y.Large pleural effusion: an unusual manifestation of Kawasaki disease. Clin Pediatr. 2004;43:389-391.
5.
Hamada H., Terai M., Honda T., et al. Marked pleural and pericardial effusion with elevated vascular endothelial growth factor production: an uncommon complication of Kawasaki disease. Pediatr Int. 2005;47:112-114.
Yavuz T., Nisli K., Yilmaz C., et al. Large pleural effusion necessitates chest tube drainage in a patient with Kawasaki disease. J Paediatr Child Health. 2007;43:191-192.
8.
Okada Y., Shinohara M., Kobayashi T., et al. Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children. J Pediatr. 2003;143: 357-362.
9.
Curtis N., Zheng R., Lamb JR, et al. Evidence for a superantigen mediated process in Kawasaki disease . Arch Dis Child. 1995;72:308-311.
10.
Suenaga T., Suzuki H., Shibuta S., et al. Detection of multiple superantigen genes in stools of patients with Kawasaki disease. J Pediatr. 2009;155:266-270.
